María Luisa Mittal1, Sonia Jain2, Shelly Sun2, Kora DeBeck3, M J Milloy3, Kanna Hayashi4, Scott E Hadland5, Dan Werb6. 1. Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA; School of Medicine, Universidad Xochicalco, Tijuana, Mexico. 2. Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, USA. 3. BC Centre on Substance Use, St. Paul's Hospital, Vancouver, Canada. 4. BC Centre on Substance Use, St. Paul's Hospital, Vancouver, Canada; Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada. 5. Division of General Pediatrics, Department of Pediatrics, Boston University School of Medicine, Boston, MA, USA; Department of Pediatrics and Grayken Center for Addiction, Boston Medical Center, Boston, MA, USA. 6. Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA. Electronic address: dwerb@ucsd.edu.
Abstract
BACKGROUND: Opioid agonist treatment (OAT) is an effective biomedical intervention to manage opioid use disorder among persons who inject drugs (PWID). Preliminary evidence suggests that OAT may also disrupt the social communicability of injection drug use (IDU) practices by established PWID. We therefore aim to investigate the association between OAT enrollment and initiating others into IDU among PWID in Vancouver, Canada. METHODS: Preventing Injecting by Modifying Existing Responses (PRIMER; NIDA DP2-DA040256-01) is a prospective multi-cohort study seeking to identify structural interventions that reduce the risk that PWID initiate others into IDU. The present analysis was conducted using data from a participating cohort of PWID in Vancouver, Canada, between December 2014 and May 2017. Multivariable logistic regression models were built to assess the association between reporting active (i.e., within the past six months) OAT enrollment and assisting others in injection initiation. A final model was determined using a manual stepwise approach whereby covariates were excluded if their removal altered the coefficient of interest by <5%. RESULTS: Participants (n = 1740) were predominantly male (62.3%); 35.1% reported daily injecting (n = 611); 860 (49.4%) reported active OAT enrollment, and 80 (4.6%) reported recently providing injection initiation assistance. In a multivariable model, participants who reported active OAT enrollment had significantly lower odds of recently providing injection initiation assistance (Adjusted Odds Ratio = 0.52, 95% Confidence Interval: 0.31-0.87, P = 0.01). CONCLUSION: Results suggest a protective association between OAT and the expansion of IDU practices among vulnerable populations, suggesting its potential use as 'addiction treatment as prevention.'
BACKGROUND: Opioid agonist treatment (OAT) is an effective biomedical intervention to manage opioid use disorder among persons who inject drugs (PWID). Preliminary evidence suggests that OAT may also disrupt the social communicability of injection drug use (IDU) practices by established PWID. We therefore aim to investigate the association between OAT enrollment and initiating others into IDU among PWID in Vancouver, Canada. METHODS: Preventing Injecting by Modifying Existing Responses (PRIMER; NIDA DP2-DA040256-01) is a prospective multi-cohort study seeking to identify structural interventions that reduce the risk that PWID initiate others into IDU. The present analysis was conducted using data from a participating cohort of PWID in Vancouver, Canada, between December 2014 and May 2017. Multivariable logistic regression models were built to assess the association between reporting active (i.e., within the past six months) OAT enrollment and assisting others in injection initiation. A final model was determined using a manual stepwise approach whereby covariates were excluded if their removal altered the coefficient of interest by <5%. RESULTS:Participants (n = 1740) were predominantly male (62.3%); 35.1% reported daily injecting (n = 611); 860 (49.4%) reported active OAT enrollment, and 80 (4.6%) reported recently providing injection initiation assistance. In a multivariable model, participants who reported active OAT enrollment had significantly lower odds of recently providing injection initiation assistance (Adjusted Odds Ratio = 0.52, 95% Confidence Interval: 0.31-0.87, P = 0.01). CONCLUSION: Results suggest a protective association between OAT and the expansion of IDU practices among vulnerable populations, suggesting its potential use as 'addiction treatment as prevention.'
Authors: Stephanie A Meyers-Pantele; Sonia Jain; Xiaoying Sun; Charles Marks; Kora DeBeck; Kanna Hayashi; Steffanie A Strathdee; Dan Werb Journal: Drug Alcohol Rev Date: 2021-10-11
Authors: Jeanette M Bowles; Sonia Jain; Xiaoying Sun; Steffanie A Strathdee; Kora DeBeck; M-J Milloy; Zachary Bouck; Dan Werb Journal: Int J Drug Policy Date: 2021-08-12
Authors: Maria L Mittal; Andrew Guise; Claudia Rafful; Patricia Gonzalez-Zuñiga; Peter Davidson; Devesh Vashishtha; Steffanie A Strathdee; Dan Werb Journal: Subst Use Misuse Date: 2019-08-07 Impact factor: 2.164
Authors: Griffin A Tyree; Nzwakie Mosery; Elizabeth F Closson; Zonke Mabude; Carol du Toit; David R Bangsberg; Steven A Safren; Kenneth H Mayer; Jennifer A Smit; Matthew J Mimiaga; David J Grelotti Journal: Int J Drug Policy Date: 2020-06-12
Authors: Sean T Allen; Kristin E Schneider; Alyona Mazhnaya; Rebecca Hamilton White; Allison O'Rourke; Alex H Kral; Ricky N Bluthenthal; Michael E Kilkenny; Susan G Sherman Journal: AIDS Behav Date: 2021-06-02